Statements & Guidelines
Whether produced alone or in partnership with other organisations, EASD statements and guidelines have significant visibility and substantial impact on health care, particularly when concerning statements on treatment and diagnostic criteria.
The Committee on Clinical Affairs (CCA) is responsible for structuring and overseeing EASD’s activities in the development of formal statements, consensus documents, and other clinical resources that complement the clinical practice guidelines.
The Guidelines Oversight Committee (GOC) is responsible for overseeing the development, implementation, and updating of clinical practice guidelines that adhere to the National Academy of Medicine (NAM) principles and Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology.
Statements and Guidelines
Glucose Management for Exercise using Continuous Glucose Monitoring (CGM) and Intermittently Scanned CGM (isCGM) Systems in Type 1 Diabetes – Position Statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA) (2020)
Precision medicine in diabetes. ADA and EASD Consensus Report (2020)
Management of hyperglycaemia in type 2 diabetes: ADA and EASD Consensus Report (2018)
2016 European Guidelines on CVD Prevention in Clinical Practice (2016)
New WHO criteria on use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus (2011)